Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Shares, $0.01 par value
-
Shares outstanding
-
29,579,010
-
Total 13F shares
-
8,708,366
-
Share change
-
-460,356
-
Total reported value
-
$145,966,923
-
Price per share
-
$16.78
-
Number of holders
-
72
-
Value change
-
-$7,099,873
-
Number of buys
-
34
-
Number of sells
-
37
Institutional Holders of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) as of Q4 2025
As of 31 Dec 2025,
abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) was held by
72 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,708,366 shares.
The largest 10 holders included
Saba Capital Management, L.P., MORGAN STANLEY, Penserra Capital Management LLC, RAYMOND JAMES FINANCIAL INC, LPL Financial LLC, NEEDHAM INVESTMENT MANAGEMENT LLC, FLAGSHIP HARBOR ADVISORS, LLC, Allspring Global Investments Holdings, LLC, RIVERNORTH CAPITAL MANAGEMENT, LLC, and AMERIPRISE FINANCIAL INC.
This page lists
72
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.